By testing multiple chemotherapies on a patient's cancer cells before treating a cancer patient, ChemoFx^® helps determine the chemotherapies that are more likely to be effective and helps guide the physician away from therapies that are more likely to be ineffective- giving cancer patients a powerful advantage in the fight against cancer.

ChemoFx^® is a drug response marker. It's a test that quantifies an individual cancer patient's probable tumor response to various chemotherapeutic and biologic agents—providing both sensitivity and resistance information. As such, ChemoFx^® provides valuable insights that help guide physicians' treatment decisions and give both physicians and patients an edge against cancer.

Each and every patient's cancer is unique. That's why we at Precision Therapeutics believe in ensuring that every patient receives treatment that is customized to his or her individual needs.

Our mission is simple: support physicians in their treatment decisions and improve the chances for a better quality of life for those living with cancer.